{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:01:55Z","timestamp":1779145315867,"version":"3.51.4"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>This Clinical Insights describes the process for initiating buprenorphine treatment for patients with opioid use disorder.<\/jats:p>","DOI":"10.1001\/jamainternmed.2024.3977","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T15:33:17Z","timestamp":1724686397000},"page":"1248","source":"Crossref","is-referenced-by-count":10,"title":["Buprenorphine for Opioid Use Disorder\u2014An Essential Medical Treatment"],"prefix":"10.1001","volume":"184","author":[{"given":"Melissa B.","family":"Weimer","sequence":"first","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale School of Public Health, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth L.","family":"Morford","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"iit240005r1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/ADM.0000000000000635","article-title":"Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder.","volume":"14","author":"Crotty","year":"2020","journal-title":"J Addict Med"},{"issue":"3","key":"iit240005r2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"iit240005r3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s11606-024-08652-7","article-title":"The MATE Act: Progress for substance use education, but is checking a box enough?","volume":"39","author":"Morford","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"6","key":"iit240005r4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM clinical considerations: buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids.","volume":"17","author":"Weimer","year":"2023","journal-title":"J Addict Med"},{"key":"iit240005r5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111040","article-title":"Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016-17.","volume":"254","author":"Heimer","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"iit240005r6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","article-title":"Home buprenorphine\/naloxone induction in primary care.","volume":"24","author":"Lee","year":"2009","journal-title":"J Gen Intern Med"},{"key":"iit240005r7","article-title":"User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial.","volume":"377","author":"Melnick","year":"2022","journal-title":"BMJ"},{"issue":"1","key":"iit240005r9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: a systematic review.","volume":"35","author":"Timko","year":"2016","journal-title":"J Addict Dis"},{"issue":"1","key":"iit240005r10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-024-00450-0","article-title":"Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims.","volume":"19","author":"Xu","year":"2024","journal-title":"Addict Sci Clin Pract"},{"key":"iit240005r8","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine quick start guide. Accessed April 1, 2024. https:\/\/www.samhsa.gov\/sites\/default\/files\/quick-start-guide.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2822387\/jamainternal_weimer_2024_it_240005_1727970880.72419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T15:01:34Z","timestamp":1728313294000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2822387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.3977","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}